Skip to main content
. 2016 Feb 5;17(1):17–28. doi: 10.1080/15284336.2015.1112494

Figure 1 .

Figure 1

Patient disposition from enrollment to eligibility. ARV, antiretroviral; ATV/r, ritonavir-boosted atazanavir; NRTI, nucleos(t)ide reverse transcriptase inhibitors.